The largest database of trusted experimental protocols

Nucleosil 100 7 c18 column

Manufactured by Macherey-Nagel
Sourced in Germany

NUCLEOSIL®100–7 C18 column is a high-performance liquid chromatography (HPLC) column designed for the separation and analysis of a wide range of compounds. The column features a silica-based stationary phase with C18 functionalization, providing a versatile platform for reversed-phase chromatography. The 100 Å pore size and 7 μm particle size contribute to the column's efficient separation capabilities.

Automatically generated - may contain errors

Lab products found in correlation

3 protocols using nucleosil 100 7 c18 column

1

Synthesis and Purification of 3-Methylbenzoyl-CoA

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 3-methylbenzoyl-CoA was synthesized from the corresponding carboxylic acid via its succinimide ester as described (44 ). The CoA ester formed was purified by preparative reversed phase HPLC on a 1525 Binary HPLC Pump system (Waters) equipped with a NUCLEOSIL®100–7 C18 column (Macherey-Nagel, 50 ml total volume) using acetonitrile in 50 mm potassium phosphate buffer, pH 6.8, at a flow rate of 8 ml min−1. The column was equilibrated with 5% acetonitrile; elution was at 25% acetonitrile in buffer. For removal of phosphate, the freeze-dried CoA ester was suspended in 2% aqueous acetonitrile; elution was with 25% aqueous acetonitrile. The purity was checked by reversed phase HPLC as described above and by the UV-visible spectrum. 3-Methylbenzoyl-CoA was stored at −20 °C as freeze-dried powder.
+ Open protocol
+ Expand
2

Purification of Brominated Peptide

Check if the same lab product or an alternative is used in the 5 most similar protocols
A cell pellet of E. coli BL21(DE3) pGro7 pET28‐Thal containing overexpressed Thal was resuspended in 20 mL of aqueous buffer (50 mM Na2HPO4, 30 mM NaBr, pH 7.4) and lysed by French‐Press (3 passages @ 1100 bar cell pressure). Cell lysate was cleared by centrifugation for 30 min (12000×g, 4 °C) and the supernatant was provided in a 100 mL Erlenmeyer flask. To the halogenase lysate, 15–40 μm peptide substrate, PrnF (2.5 U mL−1), PTDH (2 U mL−1), 0.1 mm NAD+, 10 μm FAD, 50 mm sodium phosphite, 30 mm NaBr and 15 mm Na2HPO4 (pH 7,4) were added in a total volume of 30–80 mL. Upon incubation for 20 h at 25 °C in a shaking incubator precipitate was removed by centrifugation (10000×g, 30 min, 4 °C), the crude product was freeze dried and purified by preparative RP‐HPLC on a Merck‐Hitachi preparative HPLC system (controller: D7000, pump: L7150, detector: L7420, absorbance monitored at 220 nm) equipped with a Macherey‐Nagel Nucleosil 100–7 C18 column (7 μm, 250×10 mm). A linear gradient from 0→75 % MeCN over 45 min was applied to isolate brominated peptide. Resultant product‐containing fractions were pooled, freeze‐dried and analysed by NMR and HRMS.
+ Open protocol
+ Expand
3

Oligonucleotide Synthesis and Annealing

Check if the same lab product or an alternative is used in the 5 most similar protocols
All of the oligonucleotides that were tested in this study (Table 1) were synthesized in the Laboratory of Synthetic Biology at the ICBFM SB RAS on an ASM-700 automated synthesizer (BIOSSET, Novosibirsk, Russia) using the standard phosphitamide method. The products were purified by ion exchange high-performance liquid chromatography on a Nucleosil 100-5 SB column (4.6 × 250 mm) followed by reverse-phase chromatography on a Nucleosil 100-7 C18 column (4.6 × 250 mm; Macherey-Nagel GmbH, Düren, Germany). Some oligonucleotides were labeled with carboxyfluorescein (FAM). To obtain a duplex, a labeled oligonucleotide was annealed with the complementary strand in equimolar amounts. The 50 µL reaction mixture was incubated for 5 min at 95 °C and then slowly cooled down to room temperature. The resulting oligonucleotide duplex was stored at −20 °C.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!